Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| lung | 11 studies | 25% ± 12% | |
| kidney | 9 studies | 22% ± 5% | |
| brain | 9 studies | 29% ± 11% | |
| eye | 8 studies | 32% ± 15% | |
| intestine | 6 studies | 22% ± 8% | |
| liver | 6 studies | 27% ± 17% | |
| peripheral blood | 5 studies | 24% ± 10% | |
| uterus | 4 studies | 26% ± 11% | |
| pancreas | 3 studies | 27% ± 10% | |
| breast | 3 studies | 18% ± 1% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 100% | 165.58 | 2639 / 2642 | 54% | 1.02 | 384 / 705 |
| esophagus | 98% | 80.62 | 1420 / 1445 | 40% | 0.65 | 73 / 183 |
| breast | 99% | 66.10 | 456 / 459 | 28% | 0.59 | 311 / 1118 |
| thymus | 100% | 100.44 | 651 / 653 | 25% | 0.37 | 153 / 605 |
| intestine | 100% | 81.25 | 962 / 966 | 22% | 0.38 | 117 / 527 |
| stomach | 97% | 60.82 | 350 / 359 | 23% | 0.45 | 65 / 286 |
| ovary | 100% | 166.72 | 180 / 180 | 20% | 0.32 | 84 / 430 |
| lung | 97% | 52.97 | 558 / 578 | 21% | 0.52 | 244 / 1155 |
| kidney | 100% | 99.27 | 89 / 89 | 17% | 0.29 | 154 / 901 |
| bladder | 100% | 86.38 | 21 / 21 | 15% | 0.37 | 74 / 504 |
| prostate | 100% | 85.38 | 244 / 245 | 13% | 0.24 | 63 / 502 |
| uterus | 100% | 123.43 | 170 / 170 | 9% | 0.17 | 42 / 459 |
| adrenal gland | 100% | 88.29 | 257 / 258 | 3% | 0.05 | 8 / 230 |
| blood vessel | 100% | 86.81 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| spleen | 100% | 55.76 | 241 / 241 | 0% | 0 | 0 / 0 |
| muscle | 99% | 77.51 | 796 / 803 | 0% | 0 | 0 / 0 |
| adipose | 99% | 58.73 | 1193 / 1204 | 0% | 0 | 0 / 0 |
| skin | 89% | 35.40 | 1607 / 1809 | 9% | 0.12 | 41 / 472 |
| heart | 95% | 83.30 | 822 / 861 | 0% | 0 | 0 / 0 |
| pancreas | 88% | 30.88 | 287 / 328 | 6% | 0.11 | 11 / 178 |
| liver | 77% | 23.63 | 174 / 226 | 3% | 0.05 | 14 / 406 |
| peripheral blood | 41% | 21.85 | 380 / 929 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 10% | 0.13 | 3 / 29 |
| eye | 0% | 0 | 0 / 0 | 9% | 0.12 | 7 / 80 |
| tonsil | 0% | 0 | 0 / 0 | 2% | 0.02 | 1 / 45 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0033617 | Biological process | mitochondrial cytochrome c oxidase assembly |
| GO_0005743 | Cellular component | mitochondrial inner membrane |
| GO_0005739 | Cellular component | mitochondrion |
| GO_0005515 | Molecular function | protein binding |
| Gene name | COX20 |
| Protein name | Cytochrome c oxidase assembly protein COX20, mitochondrial |
| Synonyms | FAM36A |
| Description | FUNCTION: Essential for the assembly of the mitochondrial respiratory chain complex IV (CIV), also known as cytochrome c oxidase . Acts as a chaperone in the early steps of cytochrome c oxidase subunit II (MT-CO2/COX2) maturation, stabilizing the newly synthesized protein and presenting it to metallochaperones SCO1/2 which in turn facilitates the incorporation of the mature MT-CO2/COX2 into the assembling CIV holoenzyme . . |
| Accessions | Q5RI15 ENST00000411948.7 [Q5RI15-1] ENST00000366528.3 [Q5RI15-2] |